Linperlisib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-102031-1MG | 1 mg | 61,00 | Add | |
| HY-102031-5MG | 5 mg | 115,00 | Add | |
| HY-102031-1ML | 10mM/1mL | 145,00 | Add | |
| HY-102031-10MG | 10 mg | 178,00 | Add | |
| HY-102031-25MG | 25 mg | 343,00 | Add | |
| HY-102031-50MG | 50 mg | 521,00 | Add | |
| HY-102031-100MG | 100 mg | 799,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM[1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Inflammation/Immunology, PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 2 |
| Purity | 99.51% |
| Molecular Formula | C28H37FN6O5S |
| Molecular Weight | 588.69 |
| CAS-Number | 1702816-75-8 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
